Viking Therapeutics Inc (VKTX)

Nov 22, 2025

Viking Therapeutics Stock: Clinical Trial Momentum Builds Substantial Upside - Ad-hoc-news.de

Nov 22, 2025

Nov 22, 2025

Viking Therapeutics Stock: A Turning Point Emerges - Ad-hoc-news.de

Nov 22, 2025

Nov 22, 2025

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon - The Motley Fool

Nov 22, 2025

Nov 21, 2025

Viking Therapeutics Stock: A Transformative Week for the Biotech Firm - Ad-hoc-news.de

Nov 21, 2025

Nov 21, 2025

What drives Viking Therapeutics Inc stock priceStock Price Divergence & Low Cost Portfolio Tips - earlytimes.in

Nov 21, 2025

Nov 21, 2025

Viking Therapeutics (VKTX) Up 1% Since Last Earnings Report: Can It Continue? - sharewise.com

Nov 21, 2025

Nov 21, 2025

Will Viking Therapeutics Inc. (1VT) stock deliver compounding returnsOil Prices & Fast Exit/Entry Strategy Plans - newser.com

Nov 21, 2025

Nov 21, 2025

Viking Therapeutics concludes enrolment in Phase III trial of obesity therapy - Clinical Trials Arena

Nov 21, 2025

Nov 21, 2025

3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential - Finviz

Nov 21, 2025

Nov 20, 2025

VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug - Yahoo Finance

Nov 20, 2025

Nov 20, 2025

How (VKTX) Movements Inform Risk Allocation Models - news.stocktradersdaily.com

Nov 20, 2025

Nov 20, 2025

Viking Therapeutics stock holds Buy rating as obesity trial enrollment completes - Investing.com India

Nov 20, 2025

Nov 20, 2025

Is Viking Therapeutics Inc. stock a top momentum playBull Run & Technical Pattern Recognition Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Using Bollinger Bands to evaluate Viking Therapeutics Inc.Product Launch & Reliable Entry Point Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Can Viking Therapeutics Inc. (1VT) stock sustain margin levelsWeekly Trade Review & Capital Protection Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics, Up 62% Since August, Undercuts A Buy Zone Despite Key Win - Investor's Business Daily

Nov 19, 2025

Nov 19, 2025

Can Viking Therapeutics Inc. stock reach $100 price target2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com

Nov 19, 2025

Nov 19, 2025

Viking therapeutics completes enrollment in obesity drug trial By Investing.com - Investing.com Nigeria

Nov 19, 2025

Nov 19, 2025

William Blair Reiterates “Buy” Rating on Viking Therapeutics (VKTX) Following New VK2735 Data - MSN

Nov 19, 2025

Nov 19, 2025

Why Viking Therapeutics Inc. (1VT) stock attracts HNW investorsJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Why Viking Therapeutics Inc. stock could see breakout soonJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How to Invest in Viking Therapeutics (VKTX) - The Motley Fool

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics : November 2025 Corporate Presentation - MarketScreener

Nov 19, 2025

Nov 19, 2025

Strong Enrollment and Promising Strategy Propel Viking Therapeutics to ‘Buy’ Rating - TipRanks

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics (VKTX) Stock: Investors Eye 78-Week Readout After Ahead-of-Schedule Phase 3 Progress - parameter.io

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics, Up 62% Since August, Lingers In Buy Zone On An Obesity Win - MSN

Nov 19, 2025

Nov 19, 2025

Viking: Playfield Has Changed, Downgrading To Hold After A Strong Run (NASDAQ:VKTX) - Seeking Alpha

Nov 19, 2025

Nov 19, 2025

Promising Potential of Viking Therapeutics’ VK2735 Justifies Buy Rating - TipRanks

Nov 19, 2025

Nov 19, 2025

Is Viking Therapeutics Inc. stock a buy before product launchesInflation Watch & Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - AOL.com

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics (VKTX) Completes Enrollment for Key Phase 3 Trial - GuruFocus

Nov 19, 2025

Nov 19, 2025

What consensus target says about Viking Therapeutics Inc. (1VT) stockOil Prices & Capital Protection Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Why Viking Therapeutics Inc. stock is popular among millennialsMarket Trend Summary & Verified Swing Trading Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics at Jefferies: Strategic Insights on Obesity Drug By Investing.com - Investing.com India

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics at Jefferies: Strategic Insights on Obesity Drug - Investing.com

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics Completes Enrollment in Phase 3 Vanquish 1 Obesity Trial - MarketScreener

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735 - Finviz

Nov 19, 2025

Nov 19, 2025

Viking therapeutics completes enrollment in obesity drug trial - Investing.com India

Nov 19, 2025

Nov 19, 2025

Stocks To Watch: Viking Therapeutics Sees Relative Strength Rating Rise To 89 - Investor's Business Daily

Nov 19, 2025

Nov 19, 2025

Viking Therapeutics (VKTX) completes VANQUISH-1 obesity trial for 4,650 adults - Stock Titan

Nov 19, 2025

Nov 19, 2025

Signal strength of Viking Therapeutics Inc. stock in tech scannersChart Signals & Capital Protection Trade Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

What makes Viking Therapeutics Inc. stock attractive to growth fundsJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com

Nov 18, 2025